BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3522450)

  • 1. Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects.
    Golay A; Schutz Y; Felber JP; de Fronzo RA; Jéquier E
    Int J Obes; 1986; 10(2):107-16. PubMed ID: 3522450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of glucose induced thermogenesis in obese subjects with and without diabetes: a six-year follow-up study.
    Golay A; Jallut D; Schutz Y; Felber JP; Jéquier E
    Int J Obes; 1991 Sep; 15(9):601-7. PubMed ID: 1960011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Ravussin E; Bogardus C; Schwartz RS; Robbins DC; Wolfe RR; Horton ES; Danforth E; Sims EA
    J Clin Invest; 1983 Sep; 72(3):893-902. PubMed ID: 6350368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between autonomic neuropathy and thermogenesis in non diabetic and diabetic obese patients.
    Golay A; Schutz Y; Dusmet M; Felber JP; Jequier E
    Diabete Metab; 1987 Feb; 13(1):52-7. PubMed ID: 3569633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blunted glucose-induced thermogenesis: a factor contributing to relapse of obesity.
    Golay A
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S23-7. PubMed ID: 8384175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.
    Gougeon R
    Obes Res; 2001 Apr; 9(4):241-50. PubMed ID: 11331427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obesity on resting metabolic rate and glucose-induced thermogenesis in non-insulin dependent diabetes mellitus.
    Vansant G; Van Gaal L; De Leeuw I
    Int J Obes Relat Metab Disord; 1992 Oct; 16(10):817-23. PubMed ID: 1330961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of weight loss on glucose disposal in obese and obese diabetic patients.
    Golay A; Felber JP; Dusmet M; Gomez F; Curchod B; Jéquier E
    Int J Obes; 1985; 9(3):181-91. PubMed ID: 3902687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.
    Mingrone G; DeGaetano A; Greco AV; Capristo E; Benedetti G; Castagneto M; Gasbarrini G
    Diabetologia; 1997 May; 40(5):599-605. PubMed ID: 9165230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced thermogenesis in obese subjects with or without familial history of obesity.
    Verga S; Buscemi S; Bompiani G
    Eur J Clin Nutr; 1990 May; 44(5):397-404. PubMed ID: 2387274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients.
    Potter van Loon BJ; Radder JK; Frölich M; Krans HM; Zwinderman AH; Meinders AE
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S55-61. PubMed ID: 1338387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired glucose-induced thermogenesis in skeletal muscle in obesity. The role of the sympathoadrenal system.
    Astrup A; Andersen T; Henriksen O; Christensen NJ; Bülow J; Madsen J; Quaade F
    Int J Obes; 1987; 11(1):51-66. PubMed ID: 3553049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postprandial thermogenesis and obesity: effects of glucose and fructose].
    Macor C; De Palo C; Vettor R; Sicolo N; De Palo E; Federspil G
    Minerva Endocrinol; 1990; 15(4):273-7. PubMed ID: 2099997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.